Work

Anbenitamab: First Approval

Year: 2026

Type: article

Source: Drugs

DOI: 10.1007/s40265-026-02382-2

Author: Hannah A. Blair

Institution: Springer Nature (New Zealand)

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7204873491

FWCI:

Cites: 16

Cited by:

Related to: